Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding

Journal of General Virology

Volumn 93, Issue 1, 2012, Pages 72-82

  Watterson, Daniel ^a   Kobe, Bostjan ^a   Young, Paul R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; GAG PROTEIN; GLYCOSAMINOGLYCAN; HEPARIN; MALTOSE BINDING PROTEIN; NONSTRUCTURAL PROTEIN 1; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; CELL LINE; DENGUE; DENGUE VIRUS; GLYCOSAMINOGLYCANS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS;

EID: 83755178493     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.037317-0     Document Type: Article

References (59)

1. Abd-Jamil, J., Cheah, C. Y. & AbuBakar, S. (2008). Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites. Protein Eng Des Sel 21, 605-611.
2. Akhtar, J. & Shukla, D. (2009). Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 276, 7228-7236.
3. Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J. & Marks, R. M. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3, 866-871.
4. Chen, H.-L., Her, S.-Y., Huang, K.-C., Cheng, H.-T., Wu, C.-W., Wu, S.-C. & Cheng, J.-W. (2010). Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers 94, 331-338.
5. Chu, J. J., Rajamanonmani, R., Li, J., Bhuvanakantham, R., Lescar, J. & Ng, M. L. (2005). Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol 86, 405-412.
6. de Witte, L., Bobardt, M., Chatterji, U., Degeest, G., David, G., Geijtenbeek, T. B. H. & Gallay, P. (2007). Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc Natl Acad Sci U S A 104, 19464-19469.
7. Erb, S. M., Butrapet, S., Moss, K. J., Luy, B. E., Childers, T., Calvert, A. E., Silengo, S. J., Roehrig, J. T., Huang, C. Y. & Blair, C. D. (2010). Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Virology 406, 328-335.
8. Fritz, R., Stiasny, K. & Heinz, F. X. (2008). Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol 183, 353-361.
9. Germi, R., Crance, J. M., Garin, D., Guimet, J., Lortat-Jacob, H., Ruigrok, R. W., Zarski, J. P. & Drouet, E. (2002). Heparan sulfatemediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292, 162-168.
10. Guirakhoo, F., Heinz, F. X. & Kunz, C. (1989). Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH. Virology 169, 90-99.
11. Hallak, L. K., Kwilas, S. A. & Peeples, M. E. (2007). Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. Methods Mol Biol 379, 15-34.
12. Hileman, R. E., Fromm, J. R., Weiler, J. M. & Linhardt, R. J. (1998). Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20, 156-167.
13. Hiramatsu, K., Tadano, M., Men, R. & Lai, C. J. (1996). Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/ DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 224, 437-445.
14. Huang, K. C., Lee, M. C., Wu, C. W., Huang, K. J., Lei, H. Y. & Cheng, J. W. (2008). Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein. Proteins 70, 1116-1119.
15. Hung, S. L., Lee, P. L., Chen, H. W., Chen, L. K., Kao, C. L. & King, C. C. (1999). Analysis of the steps involved in dengue virus entry into host cells. Virology 257, 156-167.
16. Hung, J. J., Hsieh, M. T., Young, M. J., Kao, C. L., King, C. C. & Chang, W. (2004). An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 78, 378-388.
17. Jindadamrongwech, S., Thepparit, C. & Smith, D. R. (2004). Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol 149, 915-927.
18. Kampmann, T., Mueller, D. S., Mark, A. E., Young, P. R. & Kobe, B. (2006). The role of histidine residues in low-pH-mediated viral membrane fusion. Structure 14, 1481-1487.
19. Kanai, R., Kar, K., Anthony, K., Gould, L. H., Ledizet, M., Fikrig, E., Marasco, W. A., Koski, R. A. & Modis, Y. (2006). Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80, 11000-11008.
20. Kroschewski, H., Allison, S. L., Heinz, F. X. & Mandl, C. W. (2003). Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology 308, 92-100.
21. Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R. & Strauss, E. G. (2002). Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725.
22. Lee, E. & Lobigs, M. (2000). Substitutions at the putative receptorbinding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol 74, 8867-8875.
23. Lee, E. & Lobigs, M. (2002). Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76, 4901-4911.
24. Lee, E., Hall, R. A. & Lobigs, M. (2004). Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78, 8271-8280.
25. Lee, E., Wright, P. J., Davidson, A. & Lobigs, M. (2006). Virulence attenuation of dengue virus due to augmented glycosaminoglycanbinding affinity and restriction in extraneural dissemination. J Gen Virol 87, 2791-2801.
26. Liao, M. & Kielian, M. (2005). Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J Cell Biol 171, 111-120.
27. Lin, B., Parrish, C. R., Murray, J. M. & Wright, P. J. (1994). Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology 202, 885-890.
28. Mackenzie, J. S., Gubler, D. J. & Petersen, L. R. (2004). Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10 (Suppl.), S98-S109.
29. Miller, J. L., de Wet, B. J., Martinez-Pomares, L., Radcliffe, C. M., Dwek, R. A., Rudd, P. M. & Gordon, S. (2008). The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4, e17.
30. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. (2003). A ligandbinding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100, 6986-6991.
31. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. (2004). Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313-319.
32. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. (2005). Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79, 1223-1231.
33. Mueller, D. S., Kampmann, T., Yennamalli, R., Young, P. R., Kobe, B. & Mark, A. E. (2008). Histidine protonation and the activation of viral fusion proteins. Biochem Soc Trans 36, 43-45.
34. Mukherjee, M., Dutta, K., White, M. A., Cowburn, D. & Fox, R. O. (2006). NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition. Protein Sci 15, 1342-1355.
35. Navarro-Sanchez, E., Altmeyer, R., Amara, A., Schwartz, O., Fieschi, F., Virelizier, J. L., Arenzana-Seisdedos, F. & Després, P. (2003). Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cellderived dengue viruses. EMBO Rep 4, 723-728.
36. Nishioka, S., Aikawa, J., Ida, M., Matsumoto, I., Street, M., Tsujimoto, M. & Kojima-Aikawa, K. (2007). Ligand-binding activity and expression profile of annexins in Caenorhabditis elegans. J Biochem 141, 47-55.
37. Pokidysheva, E., Zhang, Y., Battisti, A. J., Bator-Kelly, C. M., Chipman, P. R., Xiao, C., Gregorio, G. G., Hendrickson, W. A., Kuhn, R. J. & Rossmann, M. G. (2006). Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124, 485-493.
38. Putnak, J. R., Kanesa-Thasan, N. & Innis, B. L. (1997). A putative cellular receptor for dengue viruses. Nat Med 3, 828-829.
39. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. (1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 A ° resolution. Nature 375, 291-298.
40. Reyes-del Valle, J., Chávez-Salinas, S., Medina, F. & del Angel, R. M. (2005). Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 79, 4557-4567.
41. Roehrig, J. T., Bolin, R. A. & Kelly, R. G. (1998). Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246, 317-328.
42. Ruiz-Sáenz, J., Goez, Y., Tabares, W. & López-Herrera, A. (2009). Cellular receptors for foot and mouth disease virus. Intervirology 52, 201-212.
43. Su, C. M., Liao, C. L., Lee, Y. L. & Lin, Y. L. (2001). Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286, 206-215.
44. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S. & other authors (2003). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197, 823-829.
45. Thaisomboonsuk, B. K., Clayson, E. T., Pantuwatana, S., Vaughn, D. W. & Endy, T. P. (2005). Characterization of dengue-2 virus bindingto surfaces of mammalian and insect cells. Am J Trop Med Hyg 72, 375-383.
46. Thepparit, C. & Smith, D. R. (2004). Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 78, 12647-12656.
47. Thullier, P., Demangel, C., Bedouelle, H., Mégret, F., Jouan, A., Deubel, V., Mazié, J. C. & Lafaye, P. (2001). Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. J Gen Virol 82, 1885-1892.
48. Tio, P. H., Jong, W. W. & Cardosa, M. J. (2005). Two dimensional VOPBA reveals laminin receptor (LAMR1) interaction with dengue virus serotypes 1, 2 and 3. Virol J 2, 25.
49. Upanan, S., Kuadkitkan, A. & Smith, D. R. (2008). Identification of dengue virus binding proteins using affinity chromatography. J Virol Methods 151, 325-328.
50. Vlasak, M., Goesler, I. & Blaas, D. (2005). Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 79, 5963-5970.
51. Volk, D. E., Beasley, D. W., Kallick, D. A., Holbrook, M. R., Barrett, A. D. & Gorenstein, D. G. (2004). Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem 279, 38755-38761.
52. Volk, D. E., Chavez, L., Beasley, D. W., Barrett, A. D., Holbrook, M. R. & Gorenstein, D. G. (2006). Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology 351, 188-195.
53. Volk, D. E., Lee, Y. C., Li, X., Thiviyanathan, V., Gromowski, G. D., Li, L., Lamb, A. R., Beasley, D. W., Barrett, A. D. & Gorenstein, D. G. (2007). Solution structure of the envelope protein domain III of dengue-4 virus. Virology 364, 147-154.
54. WHO (2009). Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: World Health Organization.
55. Wu, K. P., Wu, C. W., Tsao, Y. P., Kuo, T. W., Lou, Y. C., Lin, C. W., Wu, S. C. & Cheng, J. W. (2003). Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem 278, 46007-46013.
56. Wu, C. W., Lin, Y. T., Huang, K. C. & Cheng, J. W. (2005). 1H, 15N and 13C resonance assignments of the domain III of the dengue virus envelope protein. J Biomol NMR 33, 76.
57. Yu, S., Wuu, A., Basu, R., Holbrook, M. R., Barrett, A. D. T. & Lee, J. C. (2004). Solution structure and structural dynamics of envelope protein domain III of mosquito-and tick-borne flaviviruses. Biochemistry 43, 9168-9176.
58. Zhang, Y., Zhang, W., Ogata, S., Clements, D., Strauss, J. H., Baker, T. S., Kuhn, R. J. & Rossmann, M. G. (2004). Conformational changes of the flavivirus E glycoprotein. Structure 12, 1607-1618.
59. Zhang, J. L., Wang, J. L., Gao, N., Chen, Z. T., Tian, Y. P. & An, J. (2007). Up-regulated expression of beta3 integrin induced by dengue virus serotype 2 infection associated with virus entry into human dermal microvascular endothelial cells. Biochem Biophys Res Commun 356, 763-768.